![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/353 | (2006.01) |
A61P 43/00 | (2018.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/353 | (2013.01) | ||
A61P 43/00 | (2006.01) | ||
A61K 45/06 | (2013.01) |
(11) | Number of the document | 3482760 |
(13) | Kind of document | T |
(96) | European patent application number | 17824314.3 |
Date of filing the European patent application | 2017-07-06 | |
(97) | Date of publication of the European application | 2019-05-15 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2017/024753 |
Date | 2017-07-06 |
(87) | Number | WO 2018/008711 |
Date | 2018-01-11 |
(30) | Number | Date | Country code |
201662359504 P | 2016-07-07 | US |
(72) |
YOSHIDA, Takao , JP
SHOYAMA, Akiko , JP
TAKANO, Hirotsugu , JP
|
(73) |
Ono Pharmaceutical Co., Ltd. ,
1-5, Doshomachi 2-chome
Chuo-ku, Osaka-shi, Osaka 541-8526,
JP
|
(54) | COMBINATION COMPRISING EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR |
COMBINATION COMPRISING EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR |